A phase III randomised study of carboplatin and amifostine (A) vs carboplatin and G-CSF in patients with inoperable non small cell lung cancer (NSCLC)

Anderson, H; Mercer, V; Russell, L; Habboubi, N; Thatcher, N

A phase III randomised study of carboplatin and amifostine (A) vs carboplatin and G-CSF in patients with inoperable non small cell lung cancer (NSCLC)

journal contribution

posted on 2025-06-05, 06:24 authored by H Anderson, V Mercer, L Russell, N Habboubi, N Thatcher

A phase III randomised study of carboplatin and amifostine (A) vs carboplatin and G-CSF in patients with inoperable non small cell lung cancer (NSCLC)

History

Journal

EUROPEAN JOURNAL OF CANCER

Volume

33

Pagination

55-55

ISSN

0959-8049

Language

English

Author URL

https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997XX83000055&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a045e4b2bb1f2b747c68c720ec8913b7

Publication classification

E3.1 Extract of paper

Publisher

PERGAMON-ELSEVIER SCIENCE LTD

Usage metrics

Keywords

Science & Technology Life Sciences & Biomedicine Oncology

A phase III randomised study of carboplatin and amifostine (A) vs carboplatin and G-CSF in patients with inoperable non small cell lung cancer (NSCLC)

History

Journal

Volume

Pagination

ISSN

Language

Author URL

Publication classification

Publisher

Usage metrics

Categories

Keywords

Licence

Exports